611
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Impact of self-financed rotavirus vaccination on acute gastroenteritis in young children in Turkey

ORCID Icon, , &
Pages 510-516 | Received 19 Feb 2020, Accepted 25 May 2020, Published online: 23 Jul 2020

References

  • Global Burden of Disease 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71.
  • Global Burden of Diarrhoeal Diseases Collaborators. Estimates of global, regional, national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17:909–48. doi:10.1016/S1473-3099(17)30276-1.
  • Mokomane M, Kasvosve I, de Melo E, Pernica JM, Goldfarb DM. The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management. Ther Adv Infect Dis. 2018 Jan;5(1):29–43. doi:10.1177/2049936117744429.
  • Munos MK, Walker CLF, Black RE. The effect of rotavirus vaccine on diarrhoea mortality. Int J Epidemiol. 2010;39(Suppl. 1):i56–i62. doi:10.1093/ije/dyq022.
  • WHO. Global use of rotavirus vaccines recommended (News releases). Media Centre. [accessed 2020 Feb 18]. http://www.who.int/mediacentre/news/releases/2009/rotavirus_vaccines_20090605/en//
  • Burnett E, Parashar U, Tate J. Rotavirus vaccines: effectiveness, safety, and future directions. Paediatr Drugs. 2018 Jun;20(3):223–33. doi:10.1007/s40272-018-0283-3.
  • Jonesteller CL, Burnett E, Yen C, Tate JE, Parashar UD. Effectiveness of rotavirus vaccination: a systematic review of the first decade of global postlicensure data, 2006–2016. Clin Infect Dis. 2017 Sep 1;65(5):840–50. doi:10.1093/cid/cix369.
  • WHO. Rotavirus vaccines. WHO position paper—January 2013. Wkly Epidemiol Rec. 2013;88:49–64.
  • [accessed 2020 Apr 4]. https://www.who.int/gho/immunization/rotavirus/en/.
  • Pérez-Vilar S, Díez-Domingo J, López-Lacort M, Martínez-Úbeda S, Martinez-Beneito MA. Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region, Spain. BMC Infect Dis. 2015;15:92. doi:10.1186/s12879-015-0811-5.
  • Aliabadi N, Antoni S, Mwenda JM, Weldegebriel G, Biey JNM, Cheikh D, Fahmy K, Teleb N, Ashmony HA, Ahmed H, et al. Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008-16: findings from the Global Rotavirus Surveillance Network. Lancet Glob Health. 2019 Jul;7(7):e893–e903. doi:10.1016/S2214-109X(19)30207-4.
  • Gil-Prieto R, Gonzalez-Escalada A, Alvaro-Meca A, Garcia-Garcia L, San-Martin M, González-López A, Gil-de-Miguel A. Impact of non-routine rotavirus vaccination on hospitalizations for diarrhoea and rotavirusinfections in Spain. Vaccine. 2013 Oct 9;31(43):5000–04. doi:10.1016/j.vaccine.2013.05.109. Epub 2013 Jul 30.
  • Orrico-Sanchez A, López-Lacort M, Pérez-Vilar S, Díez-Domingo J. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain. BMC Infect Dis. 2017 Apr 11;17(1):267. doi:10.1186/s12879-017-2380-2.
  • Hashizume M, Nakagomi T, Nakagomi O. An early detection of decline in rotavirus cases during the 2013/2014 season in Japan as revealed by time-series analysis of national surveillance data. Trop Med Health. 2015 Sep;43(3):177–81. doi:10.2149/tmh.2015-23.
  • Trimis G, Koutsoumbari I, Kottaridi C, Palaiologou N, Assimakopoulou E, Spathis A, Lebessi E, Konstantopoulos A, Kafetzis D, Karakitsos P, et al. Hospital-based surveillance of rotavirus gastroenteritis in the era of limited vaccine uptake through the private sector. Vaccine. 2011 Oct 6;29(43):7292–95. doi:10.1016/j.vaccine.2011.07.092.
  • Räsänen S, Lappalainen S, Halkosalo A, Salminen M, Vesikari T. Rotavirus gas- troenteritis in finnish children in 2006–2008, at the introduction of rotavirus vaccination. Scand J Infect Dis. 2011;43(1):58–63. doi:10.3109/00365548.2010.508462.
  • Gagneur A, Nowak E, Lemaitre T, Segura JF, Delapierre N, Abalea, Abalea L, Poulhazan E, Jossens A, Auzanneau L, et al. Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: the IVANHOE study. Vaccine. 2011;12:3753–59. doi:10.1016/j.vaccine.2011.03.035.
  • Wierzba TF. Oral cholera vaccines and their impact on the global burden of disease. Hum Vaccine Immunother. 2019;15(6):1294–301. doi:10.1080/21645515.2018.1504155.
  • Belmaker I, Dukhan L, Yosef Y, Leventhal A, Dagan R. Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program. Pediatr Infect Dis J. 2007;26(1):36–40. doi:10.1097/01.inf.0000247105.45185.13.
  • Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar UD. Effectiveness and impact of rotavirus vaccines in the United States - 2006–2012. Expert Rev Vaccines. 2014;13(3):365–76. doi:10.1586/14760584.2014.877846.
  • Paulke-Korinek M, Kundi M, Rendi-Wagner P, de Martin A, Eder G, Schmidle-Loss B, Vecsei A, Kollaritsch H. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine. 2011;29(15):2791–96. doi:10.1016/j.vaccine.2011.01.104.
  • Giaquinto C, Jackson AE, Vesikari T. Report of the second European expert meeting on rotavirus vaccination. Vaccine. 2012;30(13):2237–44. doi:10.1016/j.vaccine.2011.12.002.
  • Bennett A, Bar-Zeev N, Cunliffe NA. Measuring indirect effects of rotavirus vaccine in low income countries. Vaccine. 2016;34:4351–53. doi:10.1016/j.vaccine.2016.07.001.
  • Al Awaidy SA, Bawikar S, Al Busaidy S, Baqiani S, Al Abedani I, Varghesem R, Abdoan H, Al Abdoon H, Bhatnagar S, Al Hasini K. Considerations for introduction of a rotavirus vaccine in Oman: rotavirus disease and economic burden. J Infect Dis. 2009;200(Suppl 1):S248–S253. doi:10.1086/605339.
  • Muhsen K, Shulman L, Rubinstein U, Kasem E, Kremer A, Goren S, Zilberstein I, Chodick G, Ephros M, Cohen D. Incidence, characteristics, and economic burden of rotavirus gastroenteritis associated with hospitalization of Israeli children <5 years of age, 2007–2008. J Infect Dis. 2009;200(Suppl1):S254–S263. doi:10.1086/605425.
  • Giaquinto C, Van Damme P, Huet F, Gothefors L, Maxwell M, Todd P, da Dalt L. Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004–2005: the REVEAL study. J Infect Dis. 2007;195(Suppl 1):S26–S35. doi:10.1086/516717.
  • Mast TC, Walter EB, Bulotsky M, Khawaja SS, DiStefano DJ, Sandquist MK, Straus WL, Staat MA. Burden of childhood rotavirus disease on health systems in the United States. Pediatr Infect Dis J. 2010 Feb;29(2):e19–25. doi:10.1097/INF.0b013e3181ca7e2e.
  • Fischer TK, Nielsen NM, Wohlfahrt J, Paerregaard A. Incidence and cost of rotavirus hospitalizations in Denmark. Emerg Infect Dis. 2007;13:855–59. doi:10.3201/eid1306.061432.
  • Fourquet F, Desenclos JC, Maurage C, Baron S. Acute gastro-enteritis in children in France: estimates of disease burden through national hospital discharge data. Arch Pediatr. 2003;10:861–68. doi:10.1016/S0929-693X(03)00459-7.
  • Krishnarajah G, Demissie K, Lefebvre P, Gaur S, Sheng Duh M. Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States. Hum Vaccine Immunother. 2014;10(8):2255–66. doi:10.4161/hv.29511.
  • Tam CC, O’Brien SJ. Economic cost of campylobacter, norovirus and rotavirus disease in the United Kingdom. PLoS One. 2016 Feb 1;11(2):e0138526. doi:10.1371/journal.pone.0138526. eCollection 2016.
  • Mangen MJ, Bouwknegt M, Friesema IH, Haagsma JA, Kortbeek LM, Tariq L, Wilson M, van Pelt W, Havelaar AH. Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011. Int J Food Microbiol. 2015 Mar 2;196:84–93. doi:10.1016/j.ijfoodmicro.2014.11.022.
  • Lobzin YV, Kharit SM, Goveia MG, O’Brian MA, Podkolzin AT, Blokhin BM, Bekhtereva MK, Rudakova AV, Tikunova NV. Burden of childhood rotavirus disease in the outpatient setting of the Russian Federation. Pediatr Infect Dis J. 2017 May;36(5):472–76. doi:10.1097/INF.0000000000001472.
  • Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, Langley JM, Wanke C, Warren CA, Cheng AC, et al. 2017 infectious diseases society of america clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017 Nov 29;65(12):1963–73. doi:10.1093/cid/cix959.
  • Tate JE, Burton AH, Boschi-Pinto C, Parashar UD, World Health Organization–Coordinated Global Rotavirus Surveillance Network. Global, regional, and national estimates of rotavirus mortality in children <5 years of age- 2000–2013. Clin Infect Dis. 2016 May 1;62(Suppl 2):S96–S105. doi:10.1093/cid/civ1013.
  • Church JA, Rogawski McQuade ET, Mutasa K, Taniuchi M, Rukobo S, Govha M, Lee B, Carmolli MP, Chasekwa B, Ntozini R, et al. Enteropathogens and rotavirus vaccine immunogenicity in a cluster randomized trial of improved water, sanitation and hygiene in rural Zimbabwe. Pediatr Infect Dis J. 2019 Dec;38(12):1242–48. doi:10.1097/INF.0000000000002485.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.